SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1siv'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1A27_A_ESTA350_1
(17-BETA-HYDROXYSTERO
ID-DEHYDROGENASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 VAL A  62
GLY A  73
LEU A  89
ASN A  88
VAL A  33
 None
 0.99A 1a27A-1sivA:
undetectable		 1a27A-1sivA:
16.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.63A 1c6yA-1sivA:
18.1		 1c6yA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_1
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 1c6yA-1sivA:
18.1		 1c6yA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
THR A  80
ILE A  84
 None
 0.70A 1c6yB-1sivA:
17.6		 1c6yB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
ILE A  84
 None
 0.48A 1c6yB-1sivA:
17.6		 1c6yB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
THR A  80
ILE A  84
 None
 0.51A 1c6yB-1sivA:
17.6		 1c6yB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
THR A  80
PRO A  81
ILE A  84
 None
 0.46A 1c6yB-1sivA:
17.6		 1c6yB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 1c6zA-1sivA:
17.6		 1c6zA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.71A 1c6zA-1sivA:
17.6		 1c6zA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 0.56A 1c6zB-1sivA:
17.9		 1c6zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 1c6zB-1sivA:
17.9		 1c6zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.69A 1c6zB-1sivA:
17.9		 1c6zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_1
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.50A 1d4sA-1sivA:
18.2		 1d4sA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_2
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
 None
 0.67A 1d4sB-1sivA:
18.3		 1d4sB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4S_A_TPVA201_2
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
 None
 0.87A 1d4sB-1sivA:
18.3		 1d4sB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.56A 1d4yA-1sivA:
18.4		 1d4yA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.39A 1d4yA-1sivA:
18.4		 1d4yA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_2
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
 0.63A 1d4yB-1sivA:
18.4		 1d4yB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_2
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
 0.76A 1d4yB-1sivA:
18.4		 1d4yB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_2
(PROTEIN (HIV-1
PROTEASE))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
 0.55A 1d4yB-1sivA:
18.4		 1d4yB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.57A 1fb7A-1sivA:
18.1		 1fb7A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.00A 1fb7A-1sivA:
18.1		 1fb7A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.48A 1fb7A-1sivA:
18.1		 1fb7A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 1hpvA-1sivA:
18.5		 1hpvA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.59A 1hpvA-1sivA:
18.5		 1hpvA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.36A 1hpvB-1sivA:
18.6		 1hpvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 1hpvB-1sivA:
18.6		 1hpvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HPV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.72A 1hpvB-1sivA:
18.6		 1hpvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.49A 1hsgA-1sivA:
18.3		 1hsgA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.77A 1hsgA-1sivA:
18.3		 1hsgA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.31A 1hsgB-1sivA:
18.7		 1hsgB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 1.24A 1hshA-1sivA:
20.2		 1hshA-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.57A 1hshA-1sivA:
20.2		 1hshA-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.80A 1hshA-1sivA:
20.2		 1hshA-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.75A 1hshB-1sivA:
20.4		 1hshB-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 9 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.76A 1hshB-1sivA:
20.4		 1hshB-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  82
 None
 1.27A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  82
ILE A  84
 None
 0.41A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
PRO A  81
ILE A  82
ILE A  84
 None
 0.49A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.47A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.52A 1hshC-1sivA:
20.8		 1hshC-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 8 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.62A 1hshD-1sivA:
20.8		 1hshD-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ARG A   8
GLY A  51
ILE A  50
PRO A  81
ILE A  82
 None
 1.45A 1hshD-1sivA:
20.8		 1hshD-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_2
(HIV-II PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 8 ASP A  25
ALA A  28
GLY A  48
ILE A  84
 None
 0.66A 1hshD-1sivA:
20.8		 1hshD-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
 None
 1.36A 1hxbA-1sivA:
18.5		 1hxbA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 1hxbA-1sivA:
18.5		 1hxbA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.34A 1hxbB-1sivA:
18.3		 1hxbB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 1hxbB-1sivA:
18.3		 1hxbB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.73A 1hxbB-1sivA:
18.3		 1hxbB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_4
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 None
 0.29A 1hxbB-1sivA:
18.3		 1hxbB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 1hxwA-1sivA:
18.7		 1hxwA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
GLY A  48
PRO A  81
ILE A  84
 None
 0.75A 1hxwA-1sivA:
18.7		 1hxwA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
 None
 0.73A 1hxwB-1sivA:
18.4		 1hxwB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.48A 1hxwB-1sivA:
18.4		 1hxwB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.63A 1hxwB-1sivA:
18.4		 1hxwB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
PRO A  81
 None
 0.47A 1k6cA-1sivA:
18.4		 1k6cA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
 None
 1.04A 1k6cA-1sivA:
18.4		 1k6cA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.42A 1k6cB-1sivA:
18.4		 1k6cB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.43A 1k6cB-1sivA:
18.4		 1k6cB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
 None
 0.91A 1k6cB-1sivA:
18.4		 1k6cB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.36A 1muiA-1sivA:
18.2		 1muiA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 1muiA-1sivA:
18.2		 1muiA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 1muiA-1sivA:
18.2		 1muiA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.26A 1muiB-1sivA:
18.4		 1muiB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 1muiB-1sivA:
18.4		 1muiB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.80A 1muiB-1sivA:
18.4		 1muiB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 7 ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.36A 1n49A-1sivA:
18.6		 1n49A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.81A 1n49B-1sivA:
18.3		 1n49B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.90A 1n49B-1sivA:
18.3		 1n49B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.81A 1n49B-1sivA:
18.3		 1n49B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ARG A   8
GLY A  27
GLY A  49
ILE A  50
ILE A  84
 None
 0.79A 1n49C-1sivA:
18.2		 1n49C-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.94A 1n49C-1sivA:
18.2		 1n49C-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 6 ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 1n49D-1sivA:
18.8		 1n49D-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.86A 1ohrA-1sivA:
18.7		 1ohrA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.45A 1ohrA-1sivA:
18.7		 1ohrA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_2
(ASPARTYLPROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.62A 1ohrB-1sivA:
17.9		 1ohrB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.47A 1rl8A-1sivA:
18.3		 1rl8A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 1rl8A-1sivA:
18.3		 1rl8A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.98A 1rl8A-1sivA:
18.3		 1rl8A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.42A 1rl8B-1sivA:
18.3		 1rl8B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.64A 1rl8B-1sivA:
18.3		 1rl8B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1RL8_A_RITA9001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.82A 1rl8B-1sivA:
18.3		 1rl8B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.78A 1sdtA-1sivA:
18.6		 1sdtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.55A 1sdtA-1sivA:
18.6		 1sdtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.83A 1sdtA-1sivA:
18.6		 1sdtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.37A 1sdtB-1sivA:
18.8		 1sdtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 1sdtB-1sivA:
18.8		 1sdtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
ASP A  25
ALA A  28
GLY A  48
GLY A  49
ILE A  84
 None
 0.52A 1sduA-1sivA:
18.4		 1sduA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.57A 1sduA-1sivA:
18.4		 1sduA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
 None
 0.46A 1sduA-1sivA:
18.4		 1sduA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
 None
 0.57A 1sduA-1sivA:
18.4		 1sduA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.36A 1sduB-1sivA:
18.3		 1sduB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.36A 1sduB-1sivA:
18.3		 1sduB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 1sduB-1sivA:
18.3		 1sduB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.76A 1sdvA-1sivA:
18.6		 1sdvA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 1sdvA-1sivA:
18.6		 1sdvA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.90A 1sdvA-1sivA:
18.6		 1sdvA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.74A 1sdvB-1sivA:
18.7		 1sdvB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.19A 1sdvB-1sivA:
18.7		 1sdvB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 1sdvB-1sivA:
18.7		 1sdvB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ASP A  25
ALA A  28
GLY A  48
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 1sguA-1sivA:
19.0		 1sguA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
PRO A  81
 None
 0.53A 1sguB-1sivA:
19.0		 1sguB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 8 ASP A  25
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.56A 1sh9A-1sivA:
19.0		 1sh9A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
ALA A  28
ILE A  32
GLY A  48
PRO A  81
 None
 1.01A 1sh9A-1sivA:
19.0		 1sh9A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SH9_B_RITB301_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
GLY A  27
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.72A 1sh9B-1sivA:
18.9		 1sh9B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.81A 1t3rA-1sivA:
18.3		 1t3rA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 1t3rA-1sivA:
18.3		 1t3rA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.55A 1t3rA-1sivA:
18.3		 1t3rA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.49A 1t3rA-1sivA:
18.3		 1t3rA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.49A 1t3rB-1sivA:
18.5		 1t3rB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.66A 1t3rB-1sivA:
18.5		 1t3rB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.53A 1t3rB-1sivA:
18.5		 1t3rB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.79A 1t3rB-1sivA:
18.5		 1t3rB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.82A 1t7iA-1sivA:
18.3		 1t7iA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 1t7iA-1sivA:
18.3		 1t7iA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.51A 1t7iA-1sivA:
18.3		 1t7iA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.29A 1t7iB-1sivA:
18.4		 1t7iB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
THR A  80
 None
 1.34A 1t7jA-1sivA:
18.2		 1t7jA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.26A 1t7jA-1sivA:
18.2		 1t7jA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.58A 1t7jA-1sivA:
18.2		 1t7jA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.80A 1t7jA-1sivA:
18.2		 1t7jA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.32A 1t7jB-1sivA:
18.3		 1t7jB-1sivA:
49.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 6 ILE A  46
VAL A  47
VAL A  22
ILE A  36
 None
 0.87A 1uwhB-1sivA:
undetectable		 1uwhB-1sivA:
19.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 ASP A  25
GLY A  48
PRO A  81
ILE A  84
 None
 0.93A 2aofA-1sivA:
18.6		 2aofA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.36A 2aofA-1sivA:
18.6		 2aofA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOF_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.44A 2aofB-1sivA:
18.5		 2aofB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
 0.60A 2aohA-1sivA:
18.6		 2aohA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOH_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
ILE A  84
 None
 0.38A 2aohB-1sivA:
18.6		 2aohB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 ASP A  25
GLY A  49
PRO A  81
ILE A  84
 None
 0.38A 2aoiA-1sivA:
18.5		 2aoiA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOI_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 LEU A  23
ASP A  25
PRO A  81
ILE A  84
 None
 0.39A 2aoiB-1sivA:
18.6		 2aoiB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_1
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 LEU A  23
ASP A  25
GLY A  49
PRO A  81
 None
 0.50A 2aojA-1sivA:
18.5		 2aojA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AOJ_C_FRDC305_2
(POL POLYPROTEIN
PEPTIDE INHIBITOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 2aojB-1sivA:
18.6		 2aojB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.56A 2aquA-1sivA:
18.4		 2aquA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.90A 2aquA-1sivA:
18.4		 2aquA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 2aquB-1sivA:
18.4		 2aquB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.89A 2aquB-1sivA:
18.4		 2aquB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 2avoA-1sivA:
18.1		 2avoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.56A 2avoB-1sivA:
18.4		 2avoB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 2avoB-1sivA:
18.4		 2avoB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
 None
 1.44A 2avsA-1sivA:
18.6		 2avsA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
 0.48A 2avsA-1sivA:
18.6		 2avsA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.41A 2avsB-1sivA:
18.4		 2avsB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
 None
 1.39A 2avvA-1sivA:
18.5		 2avvA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  48
GLY A  49
ILE A  50
 None
 1.24A 2avvA-1sivA:
18.5		 2avvA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
 0.31A 2avvA-1sivA:
18.5		 2avvA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  48
GLY A  49
ILE A  50
ILE A  84
 None
 0.45A 2avvA-1sivA:
18.5		 2avvA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 2avvB-1sivA:
18.5		 2avvB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.76A 2avvB-1sivA:
18.5		 2avvB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
 None
 1.38A 2avvD-1sivA:
18.4		 2avvD-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.45A 2avvD-1sivA:
18.4		 2avvD-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.71A 2avvE-1sivA:
18.6		 2avvE-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.21A 2avvE-1sivA:
18.6		 2avvE-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2avvE-1sivA:
18.6		 2avvE-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.45A 2b60A-1sivA:
19.0		 2b60A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.59A 2b60A-1sivA:
19.0		 2b60A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 2b60B-1sivA:
19.1		 2b60B-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.41A 2b7zA-1sivA:
19.0		 2b7zA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.56A 2b7zA-1sivA:
19.0		 2b7zA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.47A 2b7zB-1sivA:
18.9		 2b7zB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.74A 2b7zB-1sivA:
18.9		 2b7zB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.48A 2bpxB-1sivA:
18.1		 2bpxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.57A 2bpxB-1sivA:
18.1		 2bpxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.79A 2bpxB-1sivA:
18.1		 2bpxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.30A 2f80A-1sivA:
18.5		 2f80A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.42A 2f80B-1sivA:
18.4		 2f80B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 2f81A-1sivA:
18.6		 2f81A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.20A 2f81B-1sivA:
18.5		 2f81B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.37A 2f81B-1sivA:
18.5		 2f81B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.38A 2f81B-1sivA:
18.5		 2f81B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.39A 2f8gA-1sivA:
18.5		 2f8gA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.37A 2f8gA-1sivA:
18.5		 2f8gA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
 None
 0.62A 2f8gB-1sivA:
18.5		 2f8gB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 2f8gB-1sivA:
18.5		 2f8gB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
 0.64A 2fxdA-1sivA:
17.9		 2fxdA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.39A 2fxdA-1sivA:
17.9		 2fxdA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.44A 2fxdB-1sivA:
18.6		 2fxdB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.42A 2fxdB-1sivA:
18.6		 2fxdB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 2fxeA-1sivA:
18.5		 2fxeA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_1
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.88A 2fxeA-1sivA:
18.5		 2fxeA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 2fxeB-1sivA:
18.5		 2fxeB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.93A 2fxeB-1sivA:
18.5		 2fxeB-1sivA:
51.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_A_SAMA2001_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 TYR A  59
GLY A  78
THR A  77
ASP A  79
 None
 0.84A 2g70A-1sivA:
undetectable		 2g70A-1sivA:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_B_SAMB2002_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 TYR A  59
GLY A  78
THR A  77
ASP A  79
 None
 0.78A 2g70B-1sivA:
undetectable		 2g70B-1sivA:
21.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
 None
 0.81A 2hs1A-1sivA:
17.7		 2hs1A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.60A 2hs1A-1sivA:
17.7		 2hs1A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 2hs1A-1sivA:
17.7		 2hs1A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 2hs1B-1sivA:
18.4		 2hs1B-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 2hs2A-1sivA:
17.7		 2hs2A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.38A 2hs2A-1sivA:
17.7		 2hs2A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.43A 2hs2A-1sivA:
17.7		 2hs2A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 2hs2B-1sivA:
18.3		 2hs2B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 2hs2B-1sivA:
18.3		 2hs2B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2idwA-1sivA:
18.3		 2idwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.53A 2idwA-1sivA:
18.3		 2idwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.74A 2idwB-1sivA:
18.0		 2idwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.19A 2idwB-1sivA:
18.0		 2idwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.60A 2idwB-1sivA:
18.0		 2idwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.31A 2ienA-1sivA:
18.5		 2ienA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 2ienA-1sivA:
18.5		 2ienA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.93A 2ienA-1sivA:
18.5		 2ienA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
 0.64A 2ienB-1sivA:
18.5		 2ienB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.64A 2ienB-1sivA:
18.5		 2ienB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.50A 2ienB-1sivA:
18.5		 2ienB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 2ienB-1sivA:
18.5		 2ienB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.56A 2ieoA-1sivA:
18.5		 2ieoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
 None
 1.04A 2ieoA-1sivA:
18.5		 2ieoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
 0.63A 2ieoA-1sivA:
18.5		 2ieoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.38A 2ieoB-1sivA:
18.5		 2ieoB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.40A 2ieoB-1sivA:
18.5		 2ieoB-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_A_J01A1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  93
SER A  31
ILE A  75
ALA A  92
LEU A  24
 None
 1.25A 2japA-1sivA:
undetectable		 2japA-1sivA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_B_J01B1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  93
SER A  31
ILE A  75
ALA A  92
LEU A  24
 None
 1.22A 2japB-1sivA:
undetectable		 2japB-1sivA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_C_J01C1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  93
SER A  31
ILE A  75
ALA A  92
LEU A  24
 None
 1.26A 2japC-1sivA:
undetectable		 2japC-1sivA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JAP_D_J01D1249_1
(CLAVALDEHYDE
DEHYDROGENASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  93
SER A  31
ILE A  75
ALA A  92
LEU A  24
 None
 1.24A 2japD-1sivA:
undetectable		 2japD-1sivA:
18.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.48A 2nmyA-1sivA:
17.6		 2nmyA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.58A 2nmyA-1sivA:
17.6		 2nmyA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.99A 2nmyA-1sivA:
17.6		 2nmyA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.69A 2nmyB-1sivA:
17.8		 2nmyB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.37A 2nmyB-1sivA:
17.8		 2nmyB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 2nmyB-1sivA:
17.8		 2nmyB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.30A 2nmzA-1sivA:
18.5		 2nmzA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 2nmzA-1sivA:
18.5		 2nmzA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.91A 2nmzA-1sivA:
18.5		 2nmzA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.38A 2nmzB-1sivA:
18.1		 2nmzB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 2nmzB-1sivA:
18.1		 2nmzB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMZ_B_ROCB401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.96A 2nmzB-1sivA:
18.1		 2nmzB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
 None
 0.89A 2nnkA-1sivA:
18.3		 2nnkA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.34A 2nnkA-1sivA:
18.3		 2nnkA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.41A 2nnkA-1sivA:
18.3		 2nnkA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.28A 2nnkB-1sivA:
18.3		 2nnkB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.75A 2nnkB-1sivA:
18.3		 2nnkB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
GLY A  27
ASP A  29
GLY A  48
PRO A  81
 None
 0.95A 2nnkB-1sivA:
18.3		 2nnkB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.55A 2nnpA-1sivA:
18.3		 2nnpA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.80A 2nnpA-1sivA:
18.3		 2nnpA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
 None
 0.67A 2nnpB-1sivA:
18.2		 2nnpB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
 None
 0.55A 2nnpB-1sivA:
18.2		 2nnpB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
 None
 0.61A 2nnpB-1sivA:
18.2		 2nnpB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
GLY A  48
GLY A  49
ILE A  50
PRO A  81
 None
 0.64A 2o4kA-1sivA:
18.7		 2o4kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  23
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.89A 2o4kA-1sivA:
18.7		 2o4kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.35A 2o4kA-1sivA:
18.7		 2o4kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  23
ASP A  25
ASP A  30
GLY A  48
GLY A  49
 None
 0.98A 2o4kA-1sivA:
18.7		 2o4kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 2o4kB-1sivA:
18.6		 2o4kB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.86A 2o4kB-1sivA:
18.6		 2o4kB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.86A 2o4lA-1sivA:
18.5		 2o4lA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.44A 2o4lA-1sivA:
18.5		 2o4lA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.50A 2o4lA-1sivA:
18.5		 2o4lA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.55A 2o4lB-1sivA:
18.3		 2o4lB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
ILE A  32
GLY A  48
PRO A  81
 None
 0.94A 2o4nA-1sivA:
18.6		 2o4nA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
PRO A  81
 None
 0.65A 2o4nA-1sivA:
18.6		 2o4nA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.85A 2o4nA-1sivA:
18.6		 2o4nA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4N_A_TPVA300_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
 None
 0.70A 2o4nB-1sivA:
18.3		 2o4nB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.59A 2o4pA-1sivA:
18.5		 2o4pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.42A 2o4pA-1sivA:
18.5		 2o4pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ARG A   8
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.84A 2o4pB-1sivA:
18.3		 2o4pB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  84
 None
 0.58A 2o4pB-1sivA:
18.3		 2o4pB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 2o4sA-1sivA:
18.6		 2o4sA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.74A 2o4sA-1sivA:
18.6		 2o4sA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.55A 2o4sB-1sivA:
18.7		 2o4sB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2o4sB-1sivA:
18.7		 2o4sB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 2pymA-1sivA:
18.6		 2pymA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYM_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 2pymB-1sivA:
18.6		 2pymB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.56A 2pynA-1sivA:
18.9		 2pynA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.54A 2pynB-1sivA:
18.9		 2pynB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2PYN_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.33A 2pynB-1sivA:
18.9		 2pynB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 2q5kA-1sivA:
18.4		 2q5kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 2q5kA-1sivA:
18.4		 2q5kA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.81A 2q5kB-1sivA:
18.9		 2q5kB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.86A 2q63A-1sivA:
18.5		 2q63A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 2q63A-1sivA:
18.5		 2q63A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q63_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 2q63B-1sivA:
18.6		 2q63B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2q64A-1sivA:
18.5		 2q64A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.50A 2q64B-1sivA:
18.5		 2q64B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_3
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.63A 2q64B-1sivA:
18.5		 2q64B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_4
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.29A 2q64B-1sivA:
18.5		 2q64B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.84A 2qakA-1sivA:
18.5		 2qakA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 2qakA-1sivA:
18.5		 2qakA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_3
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.56A 2qakB-1sivA:
18.5		 2qakB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QAK_A_1UNA1001_4
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.34A 2qakB-1sivA:
18.5		 2qakB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 2qhcA-1sivA:
18.3		 2qhcA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.46A 2qhcA-1sivA:
18.3		 2qhcA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.82A 2qhcA-1sivA:
18.3		 2qhcA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.53A 2qhcB-1sivA:
18.2		 2qhcB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.65A 2qhcB-1sivA:
18.2		 2qhcB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  48
GLY A  49
 None
 1.34A 2r5pA-1sivA:
18.9		 2r5pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
 0.51A 2r5pA-1sivA:
18.9		 2r5pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.33A 2r5pA-1sivA:
18.9		 2r5pA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.33A 2r5pB-1sivA:
18.9		 2r5pB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.97A 2r5pB-1sivA:
18.9		 2r5pB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  48
GLY A  49
 None
 1.35A 2r5pC-1sivA:
18.9		 2r5pC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
 0.51A 2r5pC-1sivA:
18.9		 2r5pC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.33A 2r5pC-1sivA:
18.9		 2r5pC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.46A 2r5pD-1sivA:
18.9		 2r5pD-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 2r5pD-1sivA:
18.9		 2r5pD-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 2r5qA-1sivA:
18.8		 2r5qA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 LEU A  23
ASP A  25
GLY A  48
PRO A  81
ILE A  84
 None
 0.84A 2r5qA-1sivA:
18.8		 2r5qA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.99A 2r5qB-1sivA:
18.5		 2r5qB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 2r5qB-1sivA:
18.5		 2r5qB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 2r5qC-1sivA:
18.8		 2r5qC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 LEU A  23
ASP A  25
GLY A  48
PRO A  81
ILE A  84
 None
 0.83A 2r5qC-1sivA:
18.8		 2r5qC-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.99A 2r5qD-1sivA:
18.5		 2r5qD-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 2r5qD-1sivA:
18.5		 2r5qD-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 GLY A  27
ALA A  28
ILE A  32
GLY A  48
ILE A  84
 None
 0.68A 2rkfA-1sivA:
18.6		 2rkfA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.27A 2rkfA-1sivA:
18.6		 2rkfA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2rkfA-1sivA:
18.6		 2rkfA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
 None
 0.80A 2rkfB-1sivA:
18.6		 2rkfB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.30A 2rkfB-1sivA:
18.6		 2rkfB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 2rkfB-1sivA:
18.6		 2rkfB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
PRO A  81
ILE A  84
 None
 0.94A 2rkgA-1sivA:
18.7		 2rkgA-1sivA:
51.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.29A 2rkgA-1sivA:
18.7		 2rkgA-1sivA:
51.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_1
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 2rkgA-1sivA:
18.7		 2rkgA-1sivA:
51.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 2rkgB-1sivA:
18.7		 2rkgB-1sivA:
51.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 2z54A-1sivA:
18.4		 2z54A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.35A 2z54B-1sivA:
18.4		 2z54B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.56A 2z54B-1sivA:
18.4		 2z54B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.83A 2z54B-1sivA:
18.4		 2z54B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 3bvbA-1sivA:
18.6		 3bvbA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_1
(PROTEASE
(RETROPEPSIN))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 1.04A 3bvbA-1sivA:
18.6		 3bvbA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.80A 3bvbB-1sivA:
18.4		 3bvbB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 3bvbB-1sivA:
18.4		 3bvbB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3BVB_B_017B401_2
(PROTEASE
(RETROPEPSIN))		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.48A 3bvbB-1sivA:
18.4		 3bvbB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.70A 3cywA-1sivA:
18.4		 3cywA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 3cywA-1sivA:
18.4		 3cywA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.30A 3cywB-1sivA:
18.5		 3cywB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.41A 3cywB-1sivA:
18.5		 3cywB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.37A 3cywB-1sivA:
18.5		 3cywB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.48A 3cyxA-1sivA:
18.4		 3cyxA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.68A 3cyxB-1sivA:
18.7		 3cyxB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3cyxB-1sivA:
18.7		 3cyxB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.52A 3d1xA-1sivA:
18.4		 3d1xA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.87A 3d1xA-1sivA:
18.4		 3d1xA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3d1xB-1sivA:
18.6		 3d1xB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 3d1xB-1sivA:
18.6		 3d1xB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.89A 3d1yA-1sivA:
18.4		 3d1yA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.41A 3d1yA-1sivA:
18.4		 3d1yA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.75A 3d1yB-1sivA:
18.3		 3d1yB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.50A 3d1zA-1sivA:
18.5		 3d1zA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.38A 3d1zA-1sivA:
18.5		 3d1zA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.78A 3d1zA-1sivA:
18.5		 3d1zA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.39A 3d1zB-1sivA:
18.4		 3d1zB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.16A 3d1zB-1sivA:
18.4		 3d1zB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.38A 3d1zB-1sivA:
18.4		 3d1zB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.50A 3d1zB-1sivA:
18.4		 3d1zB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 3d1zB-1sivA:
18.4		 3d1zB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
 None
 0.42A 3d20A-1sivA:
18.6		 3d20A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.19A 3d20A-1sivA:
18.6		 3d20A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 3d20A-1sivA:
18.6		 3d20A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3d20B-1sivA:
18.3		 3d20B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.42A 3d20B-1sivA:
18.3		 3d20B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 3d20B-1sivA:
18.3		 3d20B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.56A 3ebzA-1sivA:
21.2		 3ebzA-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.43A 3ebzA-1sivA:
21.2		 3ebzA-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.25A 3ebzB-1sivA:
20.8		 3ebzB-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
ILE A  50
 None
 0.45A 3ebzB-1sivA:
20.8		 3ebzB-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  47
GLY A  49
ILE A  50
ILE A  82
 None
 0.57A 3ebzB-1sivA:
20.8		 3ebzB-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.68A 3ekpA-1sivA:
18.6		 3ekpA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 8 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
ILE A  84
 None
 0.52A 3ekpA-1sivA:
18.6		 3ekpA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.78A 3ekpB-1sivA:
18.6		 3ekpB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.24A 3ekpB-1sivA:
18.6		 3ekpB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_B_478B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 3ekpB-1sivA:
18.6		 3ekpB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.30A 3ekpC-1sivA:
18.6		 3ekpC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.59A 3ekpC-1sivA:
18.6		 3ekpC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.67A 3ekpD-1sivA:
18.6		 3ekpD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.25A 3ekpD-1sivA:
18.6		 3ekpD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKP_C_478C200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 3ekpD-1sivA:
18.6		 3ekpD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.16A 3ekqA-1sivA:
18.4		 3ekqA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3ekqA-1sivA:
18.4		 3ekqA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.98A 3ekqA-1sivA:
18.4		 3ekqA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.80A 3ekqB-1sivA:
18.1		 3ekqB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.84A 3ektA-1sivA:
18.6		 3ektA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 3ektA-1sivA:
18.6		 3ektA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.37A 3ektA-1sivA:
18.6		 3ektA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.16A 3ektB-1sivA:
18.7		 3ektB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 3ektB-1sivA:
18.7		 3ektB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.84A 3ektC-1sivA:
18.6		 3ektC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.19A 3ektC-1sivA:
18.6		 3ektC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3ektC-1sivA:
18.6		 3ektC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.21A 3ektD-1sivA:
18.6		 3ektD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 3ektD-1sivA:
18.6		 3ektD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.75A 3ekvA-1sivA:
18.2		 3ekvA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.23A 3ekvA-1sivA:
18.2		 3ekvA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.58A 3ekvA-1sivA:
18.2		 3ekvA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.74A 3ekvB-1sivA:
18.4		 3ekvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.77A 3ekvB-1sivA:
18.4		 3ekvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.28A 3ekvB-1sivA:
18.4		 3ekvB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 1.04A 3ekwA-1sivA:
18.8		 3ekwA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 3ekwA-1sivA:
18.8		 3ekwA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 3ekwB-1sivA:
18.2		 3ekwB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.86A 3ekxA-1sivA:
18.5		 3ekxA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.37A 3ekxA-1sivA:
18.5		 3ekxA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.50A 3ekxA-1sivA:
18.5		 3ekxA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.41A 3ekxB-1sivA:
18.5		 3ekxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3ekxB-1sivA:
18.5		 3ekxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.64A 3ekxB-1sivA:
18.5		 3ekxB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 3ekyA-1sivA:
18.5		 3ekyA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.94A 3ekyA-1sivA:
18.5		 3ekyA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 3ekyB-1sivA:
18.4		 3ekyB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.98A 3ekyB-1sivA:
18.4		 3ekyB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.38A 3el0A-1sivA:
17.8		 3el0A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.77A 3el0B-1sivA:
18.3		 3el0B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.61A 3el1A-1sivA:
18.3		 3el1A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 3el1A-1sivA:
18.3		 3el1A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 3el1B-1sivA:
18.4		 3el1B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.74A 3el1B-1sivA:
18.4		 3el1B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.41A 3el4A-1sivA:
18.3		 3el4A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.82A 3el4A-1sivA:
18.3		 3el4A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.80A 3el4B-1sivA:
18.3		 3el4B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3el5A-1sivA:
18.4		 3el5A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.50A 3el5A-1sivA:
18.4		 3el5A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
 None
 0.99A 3el5A-1sivA:
18.4		 3el5A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.56A 3el5B-1sivA:
18.4		 3el5B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.93A 3el5B-1sivA:
18.4		 3el5B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 8 ARG A   8
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 3el9A-1sivA:
18.3		 3el9A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.51A 3el9A-1sivA:
18.3		 3el9A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 8 GLY A  51
ILE A  50
PRO A  81
THR A  80
 None
 0.85A 3el9A-1sivA:
18.3		 3el9A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.57A 3el9B-1sivA:
18.5		 3el9B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.27A 3em3A-1sivA:
18.8		 3em3A-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.37A 3em3B-1sivA:
18.8		 3em3B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.52A 3em3B-1sivA:
18.8		 3em3B-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.54A 3em4A-1sivA:
18.9		 3em4A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.56A 3em4B-1sivA:
18.6		 3em4B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 3em4B-1sivA:
18.6		 3em4B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.61A 3em4U-1sivA:
18.8		 3em4U-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
ASP A  29
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 0.64A 3em4V-1sivA:
18.8		 3em4V-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.28A 3em6A-1sivA:
18.5		 3em6A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.79A 3em6A-1sivA:
18.5		 3em6A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.25A 3em6A-1sivA:
18.5		 3em6A-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.48A 3em6B-1sivA:
18.7		 3em6B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.55A 3em6B-1sivA:
18.7		 3em6B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.49A 3em6B-1sivA:
18.7		 3em6B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM6_A_017A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.86A 3em6B-1sivA:
18.7		 3em6B-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.29A 3gguA-1sivA:
19.2		 3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 0.41A 3gguA-1sivA:
19.2		 3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3gguA-1sivA:
19.2		 3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.49A 3gguA-1sivA:
19.2		 3gguA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.87A 3gguB-1sivA:
19.2		 3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
THR A  80
 None
 1.29A 3gguB-1sivA:
19.2		 3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 3gguB-1sivA:
19.2		 3gguB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GGU_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.32A 3gguB-1sivA:
19.2		 3gguB-1sivA:
47.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA304_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 4 GLN A  18
PRO A  19
VAL A  20
GLU A  21
 None
 1.38A 3huoA-1sivA:
0.0		 3huoA-1sivA:
16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.84A 3jvyA-1sivA:
18.4		 3jvyA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.52A 3jvyA-1sivA:
18.4		 3jvyA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 3jvyA-1sivA:
18.4		 3jvyA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.56A 3jvyB-1sivA:
18.2		 3jvyB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 3jvyB-1sivA:
18.2		 3jvyB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
 None
 1.45A 3jw2A-1sivA:
18.9		 3jw2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 3jw2A-1sivA:
18.9		 3jw2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_1
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 1.00A 3jw2A-1sivA:
18.9		 3jw2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.27A 3jw2B-1sivA:
18.3		 3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 3jw2B-1sivA:
18.3		 3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.83A 3jw2B-1sivA:
18.3		 3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JW2_A_017A401_2
(GAG-POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.49A 3jw2B-1sivA:
18.3		 3jw2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.92A 3k4vA-1sivA:
18.2		 3k4vA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.25A 3k4vA-1sivA:
18.2		 3k4vA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 3k4vA-1sivA:
18.2		 3k4vA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.76A 3k4vB-1sivA:
18.4		 3k4vB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.31A 3k4vB-1sivA:
18.4		 3k4vB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 3k4vB-1sivA:
18.4		 3k4vB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_B_ROCB201_4
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 4 ARG A   8
ASP A  29
GLY A  48
THR A  80
 None
 1.04A 3k4vB-1sivA:
18.4		 3k4vB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.79A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.59A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.07A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.60A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.49A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 None
 0.33A 3k4vC-1sivA:
18.1		 3k4vC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 3k4vD-1sivA:
18.1		 3k4vD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 3lzsA-1sivA:
19.0		 3lzsA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 3lzsB-1sivA:
18.9		 3lzsB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 3lzuA-1sivA:
18.9		 3lzuA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.84A 3lzuB-1sivA:
18.8		 3lzuB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.38A 3lzuB-1sivA:
18.8		 3lzuB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.62A 3lzuB-1sivA:
18.8		 3lzuB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.83A 3lzvA-1sivA:
18.0		 3lzvA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.56A 3lzvA-1sivA:
18.0		 3lzvA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 3lzvB-1sivA:
18.1		 3lzvB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZV_A_017A200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.78A 3lzvB-1sivA:
18.1		 3lzvB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
ILE A  84
 None
 0.53A 3mwsA-1sivA:
19.1		 3mwsA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.50A 3mwsA-1sivA:
19.1		 3mwsA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 3mwsA-1sivA:
19.1		 3mwsA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.41A 3mwsA-1sivA:
19.1		 3mwsA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.35A 3mwsB-1sivA:
18.9		 3mwsB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3mwsB-1sivA:
18.9		 3mwsB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3mwsB-1sivA:
18.9		 3mwsB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 3mwsB-1sivA:
18.9		 3mwsB-1sivA:
49.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N3I_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.35A 3n3iA-1sivA:
13.1		 3n3iA-1sivA:
29.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N3I_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
 None
 0.48A 3n3iA-1sivA:
13.1		 3n3iA-1sivA:
29.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 3ndtA-1sivA:
18.1		 3ndtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.30A 3ndtA-1sivA:
18.1		 3ndtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 3ndtA-1sivA:
18.1		 3ndtA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.82A 3ndtB-1sivA:
18.4		 3ndtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.80A 3ndtB-1sivA:
18.4		 3ndtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.41A 3ndtB-1sivA:
18.4		 3ndtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_A_ROCA101_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 3ndtB-1sivA:
18.4		 3ndtB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.71A 3ndtC-1sivA:
18.1		 3ndtC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.31A 3ndtC-1sivA:
18.1		 3ndtC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3ndtC-1sivA:
18.1		 3ndtC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.94A 3ndtD-1sivA:
18.1		 3ndtD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.30A 3ndtD-1sivA:
18.1		 3ndtD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 3ndtD-1sivA:
18.1		 3ndtD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 3nduA-1sivA:
18.2		 3nduA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 3nduA-1sivA:
18.2		 3nduA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 3nduA-1sivA:
18.2		 3nduA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 3nduB-1sivA:
18.4		 3nduB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.37A 3nduB-1sivA:
18.4		 3nduB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.72A 3nduC-1sivA:
18.2		 3nduC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 3nduC-1sivA:
18.2		 3nduC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3nduD-1sivA:
17.8		 3nduD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 3nduD-1sivA:
17.8		 3nduD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 3ndwA-1sivA:
18.4		 3ndwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3ndwA-1sivA:
18.4		 3ndwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 0.61A 3ndwB-1sivA:
18.0		 3ndwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.75A 3ndwB-1sivA:
18.0		 3ndwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.06A 3ndxA-1sivA:
18.4		 3ndxA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3ndxA-1sivA:
18.4		 3ndxA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.50A 3ndxA-1sivA:
18.4		 3ndxA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.39A 3ndxB-1sivA:
18.2		 3ndxB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.55A 3ndxB-1sivA:
18.2		 3ndxB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.76A 3ndxB-1sivA:
18.2		 3ndxB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.50A 3nu3A-1sivA:
18.6		 3nu3A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 3nu3A-1sivA:
18.6		 3nu3A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 1.08A 3nu3A-1sivA:
18.6		 3nu3A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.30A 3nu3B-1sivA:
18.4		 3nu3B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.50A 3nu3B-1sivA:
18.4		 3nu3B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.72A 3nu3B-1sivA:
18.4		 3nu3B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  32
ILE A  50
PRO A  81
ILE A  84
 None
 0.67A 3nu4A-1sivA:
18.5		 3nu4A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.88A 3nu4A-1sivA:
18.5		 3nu4A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 3nu4A-1sivA:
18.5		 3nu4A-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3nu4B-1sivA:
18.2		 3nu4B-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3nu4B-1sivA:
18.2		 3nu4B-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.53A 3nu5A-1sivA:
18.5		 3nu5A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 1.02A 3nu5A-1sivA:
18.5		 3nu5A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.32A 3nu5A-1sivA:
18.5		 3nu5A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.37A 3nu5B-1sivA:
18.4		 3nu5B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.57A 3nu5B-1sivA:
18.4		 3nu5B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.76A 3nu6A-1sivA:
18.4		 3nu6A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.80A 3nu6A-1sivA:
18.4		 3nu6A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 3nu6A-1sivA:
18.4		 3nu6A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 1.03A 3nu6B-1sivA:
18.4		 3nu6B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.38A 3nu6B-1sivA:
18.4		 3nu6B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU6_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
 0.45A 3nu6B-1sivA:
18.4		 3nu6B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 8 ASP A  25
ALA A  28
ASP A  30
PRO A  81
 None
 0.64A 3nu9A-1sivA:
18.4		 3nu9A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.27A 3nu9A-1sivA:
18.4		 3nu9A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 3nu9B-1sivA:
18.5		 3nu9B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU9_A_478A401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
 0.41A 3nu9B-1sivA:
18.5		 3nu9B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.64A 3nujA-1sivA:
18.6		 3nujA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.86A 3nujA-1sivA:
18.6		 3nujA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.21A 3nujA-1sivA:
18.6		 3nujA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 3nujB-1sivA:
18.3		 3nujB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.48A 3nujB-1sivA:
18.3		 3nujB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.57A 3nuoA-1sivA:
18.6		 3nuoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.92A 3nuoA-1sivA:
18.6		 3nuoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.32A 3nuoA-1sivA:
18.6		 3nuoA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3nuoB-1sivA:
18.2		 3nuoB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 3nuoB-1sivA:
18.2		 3nuoB-1sivA:
50.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.63A 3ogpA-1sivA:
15.7		 3ogpA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 0.42A 3ogpA-1sivA:
15.7		 3ogpA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
 None
 0.54A 3ogpA-1sivA:
15.7		 3ogpA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_A_017A200_2
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.33A 3ogpB-1sivA:
15.9		 3ogpB-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.53A 3ogpA-1sivA:
15.7		 3ogpA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_2
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.80A 3ogpB-1sivA:
15.9		 3ogpB-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGP_B_017B200_2
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.39A 3ogpB-1sivA:
15.9		 3ogpB-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  48
 None
 0.79A 3ogqA-1sivA:
15.6		 3ogqA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 0.33A 3ogqA-1sivA:
15.6		 3ogqA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_1
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
 None
 0.49A 3ogqA-1sivA:
15.6		 3ogqA-1sivA:
28.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 0.50A 3ogqB-1sivA:
15.8		 3ogqB-1sivA:
28.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.68A 3oxcA-1sivA:
17.7		 3oxcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.39A 3oxcA-1sivA:
17.7		 3oxcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.42A 3oxcA-1sivA:
17.7		 3oxcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		3 / 3 ARG A   8
LEU A  23
THR A  80
 None
 0.61A 3oxcA-1sivA:
17.7		 3oxcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
PRO A  81
ILE A  84
 None
 0.73A 3oxcB-1sivA:
17.6		 3oxcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 3oxcB-1sivA:
17.6		 3oxcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3oxcB-1sivA:
17.6		 3oxcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.64A 3oxvA-1sivA:
18.7		 3oxvA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.32A 3oxvA-1sivA:
18.7		 3oxvA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.66A 3oxvB-1sivA:
18.9		 3oxvB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.79A 3oxvB-1sivA:
18.9		 3oxvB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.19A 3oxvB-1sivA:
18.9		 3oxvB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.35A 3oxvC-1sivA:
18.6		 3oxvC-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 3oxvD-1sivA:
18.7		 3oxvD-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.77A 3oxvD-1sivA:
18.7		 3oxvD-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.23A 3oxwA-1sivA:
18.6		 3oxwA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.80A 3oxwB-1sivA:
18.8		 3oxwB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.28A 3oxwB-1sivA:
18.8		 3oxwB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.39A 3oxwB-1sivA:
18.8		 3oxwB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.84A 3oxwC-1sivA:
18.7		 3oxwC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.22A 3oxwC-1sivA:
18.7		 3oxwC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.48A 3oxwC-1sivA:
18.7		 3oxwC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 3oxwD-1sivA:
18.7		 3oxwD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.19A 3oxwD-1sivA:
18.7		 3oxwD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.35A 3oxwD-1sivA:
18.7		 3oxwD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
GLY A  27
GLY A  49
PRO A  81
ILE A  84
 None
 0.62A 3oxxA-1sivA:
18.6		 3oxxA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.40A 3oxxA-1sivA:
18.6		 3oxxA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 3oxxB-1sivA:
18.9		 3oxxB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.44A 3oxxC-1sivA:
18.3		 3oxxC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.61A 3oxxD-1sivA:
18.9		 3oxxD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.85A 3oxxD-1sivA:
18.9		 3oxxD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.37A 3oy4A-1sivA:
18.3		 3oy4A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.73A 3oy4A-1sivA:
18.3		 3oy4A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.55A 3oy4A-1sivA:
18.3		 3oy4A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.96A 3oy4A-1sivA:
18.3		 3oy4A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.78A 3oy4B-1sivA:
18.1		 3oy4B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 3oy4B-1sivA:
18.1		 3oy4B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.55A 3oy4B-1sivA:
18.1		 3oy4B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.42A 3oy4B-1sivA:
18.1		 3oy4B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.42A 3pwmA-1sivA:
18.5		 3pwmA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.35A 3pwmA-1sivA:
18.5		 3pwmA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.31A 3pwmA-1sivA:
18.5		 3pwmA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.44A 3pwmB-1sivA:
18.5		 3pwmB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 3pwmB-1sivA:
18.5		 3pwmB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.90A 3pwrA-1sivA:
18.4		 3pwrA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.46A 3pwrA-1sivA:
18.4		 3pwrA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
LEU A  23
GLY A  49
ILE A  50
ILE A  84
 None
 0.64A 3pwrB-1sivA:
18.6		 3pwrB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.43A 3pwrB-1sivA:
18.6		 3pwrB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  82
ILE A  84
 None
 0.55A 3s43A-1sivA:
18.4		 3s43A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ILE A  32
GLY A  48
ILE A  82
ILE A  84
 None
 0.91A 3s43A-1sivA:
18.4		 3s43A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
 0.37A 3s43A-1sivA:
18.4		 3s43A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.24A 3s43B-1sivA:
18.2		 3s43B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  84
 None
 0.45A 3s43B-1sivA:
18.2		 3s43B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
 1.35A 3s45A-1sivA:
21.2		 3s45A-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 9 ASP A  25
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.46A 3s45A-1sivA:
21.2		 3s45A-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.97A 3s45A-1sivA:
21.2		 3s45A-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
 None
 0.89A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.28A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  82
 None
 0.61A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  82
ILE A  84
 None
 0.53A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 None
 0.57A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  84
 None
 0.51A 3s45B-1sivA:
20.8		 3s45B-1sivA:
86.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  82
 None
 1.31A 3s53A-1sivA:
17.7		 3s53A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  82
 None
 0.55A 3s53A-1sivA:
17.7		 3s53A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  82
 None
 0.78A 3s53A-1sivA:
17.7		 3s53A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.79A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  82
ILE A  84
 None
 0.63A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
PRO A  81
ILE A  82
ILE A  84
 None
 0.48A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ARG A   8
LEU A  23
ASP A  29
PRO A  81
ILE A  82
 None
 0.85A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.63A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.44A 3s53B-1sivA:
18.2		 3s53B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
 1.30A 3s54A-1sivA:
18.4		 3s54A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.42A 3s54A-1sivA:
18.4		 3s54A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.84A 3s54A-1sivA:
18.4		 3s54A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.20A 3s54B-1sivA:
18.4		 3s54B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.49A 3s54B-1sivA:
18.4		 3s54B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S54_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  82
ILE A  84
 None
 0.83A 3s54B-1sivA:
18.4		 3s54B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ALA A  28
ASP A  29
ILE A  32
GLY A  48
THR A  80
PRO A  81
 None
 0.91A 3s56A-1sivA:
18.1		 3s56A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.13A 3s56A-1sivA:
18.1		 3s56A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  82
 None
 0.49A 3s56A-1sivA:
18.1		 3s56A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.54A 3s56A-1sivA:
18.1		 3s56A-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.28A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 ARG A   8
LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.75A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.80A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
 1.32A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.79A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_B_ROCB203_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ARG A   8
GLU A  21
LEU A  23
PRO A  81
 None
 0.84A 3s56B-1sivA:
17.8		 3s56B-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 None
 0.84A 3so9A-1sivA:
17.9		 3so9A-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
 None
 0.97A 3so9A-1sivA:
17.9		 3so9A-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.75A 3so9B-1sivA:
17.8		 3so9B-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  23
ASP A  29
ASP A  30
ILE A  50
PRO A  81
 None
 0.92A 3so9B-1sivA:
17.8		 3so9B-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  23
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 0.62A 3so9B-1sivA:
17.8		 3so9B-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.66A 3spkA-1sivA:
18.8		 3spkA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.84A 3spkA-1sivA:
18.8		 3spkA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
LEU A  23
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.38A 3spkA-1sivA:
18.8		 3spkA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ARG A   8
LEU A  23
ALA A  28
GLY A  49
 None
 0.39A 3spkB-1sivA:
19.0		 3spkB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ARG A   8
LEU A  23
GLY A  49
ILE A  50
 None
 0.61A 3spkB-1sivA:
19.0		 3spkB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ARG A   8
LEU A  23
ALA A  28
GLY A  49
ILE A  50
 None
 0.73A 3spkA-1sivA:
18.8		 3spkA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ARG A   8
LEU A  23
ALA A  28
GLY A  49
PRO A  81
 None
 0.96A 3spkA-1sivA:
18.8		 3spkA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.46A 3spkB-1sivA:
19.0		 3spkB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.67A 3spkB-1sivA:
19.0		 3spkB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ARG A   8
LEU A  23
ASP A  29
GLY A  49
ILE A  50
 None
 0.91A 3spkB-1sivA:
19.0		 3spkB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
 None
 0.48A 3t3cA-1sivA:
18.4		 3t3cA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
 None
 0.71A 3t3cB-1sivA:
19.2		 3t3cB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.47A 3t3cB-1sivA:
19.2		 3t3cB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.96A 3tkgA-1sivA:
18.1		 3tkgA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 3tkgA-1sivA:
18.1		 3tkgA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.38A 3tkgB-1sivA:
18.2		 3tkgB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.53A 3tkgB-1sivA:
18.2		 3tkgB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.92A 3tkgC-1sivA:
18.0		 3tkgC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
PRO A  81
ILE A  84
 None
 0.43A 3tkgC-1sivA:
18.0		 3tkgC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.50A 3tkgC-1sivA:
18.0		 3tkgC-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.68A 3tkgD-1sivA:
18.2		 3tkgD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
GLY A  27
ASP A  30
GLY A  49
ILE A  50
 None
 0.59A 3tkgD-1sivA:
18.2		 3tkgD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
 0.40A 3tkgD-1sivA:
18.2		 3tkgD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.28A 3tkgD-1sivA:
18.2		 3tkgD-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
 None
 1.39A 3tkwA-1sivA:
18.5		 3tkwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.47A 3tkwA-1sivA:
18.5		 3tkwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.39A 3tkwA-1sivA:
18.5		 3tkwA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.64A 3tkwB-1sivA:
17.6		 3tkwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.21A 3tkwB-1sivA:
17.6		 3tkwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 3tkwB-1sivA:
17.6		 3tkwB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.90A 3tl9A-1sivA:
18.5		 3tl9A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.28A 3tl9A-1sivA:
18.5		 3tl9A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 3tl9A-1sivA:
18.5		 3tl9A-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 3tl9B-1sivA:
17.7		 3tl9B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_3
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.59A 3tl9B-1sivA:
17.7		 3tl9B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_4
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 4 ASP A  29
ASP A  30
GLY A  48
THR A  80
 None
 0.15A 3tl9B-1sivA:
17.7		 3tl9B-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.34A 3ttpA-1sivA:
19.3		 3ttpA-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 3ttpA-1sivA:
19.3		 3ttpA-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.57A 3ttpA-1sivA:
19.3		 3ttpA-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.38A 3ttpB-1sivA:
19.4		 3ttpB-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 3ttpB-1sivA:
19.4		 3ttpB-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
GLY A  48
ILE A  84
 None
 0.59A 3ttpB-1sivA:
19.4		 3ttpB-1sivA:
52.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.88A 3u7sA-1sivA:
18.7		 3u7sA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 3u7sA-1sivA:
18.7		 3u7sA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.44A 3u7sA-1sivA:
18.7		 3u7sA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.37A 3u7sB-1sivA:
19.2		 3u7sB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.49A 3u7sB-1sivA:
19.2		 3u7sB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 3u7sA-1sivA:
18.7		 3u7sA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_1
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.60A 3u7sA-1sivA:
18.7		 3u7sA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A202_2
(POL POLYPROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.36A 3u7sB-1sivA:
19.2		 3u7sB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
 None
 0.52A 3ucbA-1sivA:
19.4		 3ucbA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.40A 3ucbB-1sivA:
18.9		 3ucbB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.91A 3ufnA-1sivA:
19.3		 3ufnA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
VAL A  47
GLY A  48
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.51A 3ufnA-1sivA:
19.3		 3ufnA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 7 ASP A  25
VAL A  47
GLY A  49
ILE A  50
 None
 0.62A 3ufnB-1sivA:
18.8		 3ufnB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ILE A  84
 None
 0.40A 3wsjA-1sivA:
12.4		 3wsjA-1sivA:
36.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3WSJ_A_MK1A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 ARG A   8
LEU A  23
ASP A  25
ALA A  28
VAL A  47
ILE A  84
 None
 0.72A 3wsjB-1sivA:
12.6		 3wsjB-1sivA:
36.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.46A 4dqbA-1sivA:
18.5		 4dqbA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4dqbA-1sivA:
18.5		 4dqbA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.77A 4dqbA-1sivA:
18.5		 4dqbA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.79A 4dqbB-1sivA:
18.1		 4dqbB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.17A 4dqbB-1sivA:
18.1		 4dqbB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.53A 4dqbB-1sivA:
18.1		 4dqbB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.45A 4dqcA-1sivA:
18.2		 4dqcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.43A 4dqcA-1sivA:
18.2		 4dqcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.78A 4dqcA-1sivA:
18.2		 4dqcA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.78A 4dqcB-1sivA:
18.5		 4dqcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.17A 4dqcB-1sivA:
18.5		 4dqcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.43A 4dqcB-1sivA:
18.5		 4dqcB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.35A 4dqeA-1sivA:
18.3		 4dqeA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.38A 4dqeA-1sivA:
18.3		 4dqeA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.94A 4dqeA-1sivA:
18.3		 4dqeA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.79A 4dqeB-1sivA:
18.3		 4dqeB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqeB-1sivA:
18.3		 4dqeB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.50A 4dqeB-1sivA:
18.3		 4dqeB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.40A 4dqfA-1sivA:
18.0		 4dqfA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.67A 4dqfA-1sivA:
18.0		 4dqfA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.48A 4dqfA-1sivA:
18.0		 4dqfA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.99A 4dqfA-1sivA:
18.0		 4dqfA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.73A 4dqfB-1sivA:
18.0		 4dqfB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.19A 4dqfB-1sivA:
18.0		 4dqfB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.59A 4dqfB-1sivA:
18.0		 4dqfB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.47A 4dqfB-1sivA:
18.0		 4dqfB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.39A 4dqhA-1sivA:
18.4		 4dqhA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4dqhA-1sivA:
18.4		 4dqhA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_1
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.96A 4dqhA-1sivA:
18.4		 4dqhA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.77A 4dqhB-1sivA:
18.3		 4dqhB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 4dqhB-1sivA:
18.3		 4dqhB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.53A 4dqhB-1sivA:
18.3		 4dqhB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4EYR_B_RITB301_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.59A 4eyrB-1sivA:
17.9		 4eyrB-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.40A 4hlaA-1sivA:
18.5		 4hlaA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 4hlaA-1sivA:
18.5		 4hlaA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.47A 4hlaB-1sivA:
18.4		 4hlaB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4J5J_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
 None
 0.36A 4j5jB-1sivA:
18.9		 4j5jB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.73A 4jecA-1sivA:
18.3		 4jecA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.25A 4jecA-1sivA:
18.3		 4jecA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.47A 4jecA-1sivA:
18.3		 4jecA-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.48A 4jecB-1sivA:
18.4		 4jecB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.41A 4jecB-1sivA:
18.4		 4jecB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 4jecB-1sivA:
18.4		 4jecB-1sivA:
51.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.64A 4l1aA-1sivA:
17.6		 4l1aA-1sivA:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.99A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.44A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 8 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.21A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.44A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.84A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.17A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.84A 4ll3A-1sivA:
18.6		 4ll3A-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.37A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ARG A   8
ASP A  25
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.46A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.85A 4ll3B-1sivA:
18.6		 4ll3B-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.69A 4njtA-1sivA:
18.5		 4njtA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.97A 4njtA-1sivA:
18.5		 4njtA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.32A 4njtA-1sivA:
18.5		 4njtA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.87A 4njtB-1sivA:
18.6		 4njtB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 4njtB-1sivA:
18.6		 4njtB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.49A 4njtB-1sivA:
18.6		 4njtB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 4njtC-1sivA:
18.5		 4njtC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.93A 4njtC-1sivA:
18.5		 4njtC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.35A 4njtC-1sivA:
18.5		 4njtC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_D_017D101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
 None
 0.41A 4njtD-1sivA:
18.6		 4njtD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.54A 4njuA-1sivA:
18.5		 4njuA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.38A 4njuA-1sivA:
18.5		 4njuA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.78A 4njuB-1sivA:
18.7		 4njuB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.55A 4njuC-1sivA:
18.4		 4njuC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
 None
 1.40A 4njuC-1sivA:
18.4		 4njuC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.79A 4njuD-1sivA:
18.7		 4njuD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.57A 4njvA-1sivA:
18.3		 4njvA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 4njvA-1sivA:
18.3		 4njvA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 GLY A  51
ILE A  50
PRO A  81
THR A  80
ILE A  54
 None
 0.98A 4njvA-1sivA:
18.3		 4njvA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ARG A   8
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.70A 4njvB-1sivA:
18.3		 4njvB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.19A 4njvB-1sivA:
18.3		 4njvB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 4njvB-1sivA:
18.3		 4njvB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 ASP A  25
GLY A  27
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.96A 4njvB-1sivA:
18.3		 4njvB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ARG A   8
ASP A  25
GLY A  27
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.66A 4njvC-1sivA:
18.4		 4njvC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 ASP A  25
GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.44A 4njvC-1sivA:
18.4		 4njvC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
GLY A  27
GLY A  48
PRO A  81
ILE A  84
 None
 0.97A 4njvC-1sivA:
18.4		 4njvC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.61A 4njvD-1sivA:
18.3		 4njvD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4njvD-1sivA:
18.3		 4njvD-1sivA:
48.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLM_A_198A1001_2
(ANDROGEN RECEPTOR)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 6 ASN A  83
ILE A  64
ILE A  15
VAL A  62
 None
 0.86A 4olmA-1sivA:
undetectable		 4olmA-1sivA:
14.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.42A 4q1wA-1sivA:
18.2		 4q1wA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.22A 4q1wA-1sivA:
18.2		 4q1wA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.52A 4q1wA-1sivA:
18.2		 4q1wA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
 None
 0.81A 4q1wA-1sivA:
18.2		 4q1wA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.41A 4q1wA-1sivA:
18.2		 4q1wA-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ARG A   8
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 4q1wB-1sivA:
18.3		 4q1wB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ARG A   8
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.49A 4q1wB-1sivA:
18.3		 4q1wB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.82A 4q1wB-1sivA:
18.3		 4q1wB-1sivA:
49.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 4q1xA-1sivA:
18.3		 4q1xA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 None
 0.58A 4q1xA-1sivA:
18.3		 4q1xA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
 None
 0.85A 4q1xA-1sivA:
18.3		 4q1xA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.43A 4q1xA-1sivA:
18.3		 4q1xA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 1.44A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.77A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.58A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  84
 None
 0.87A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  30
ILE A  32
ILE A  50
PRO A  81
ILE A  84
 None
 0.83A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1X_A_017A101_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.51A 4q1xB-1sivA:
18.4		 4q1xB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
 None
 0.79A 4q1yA-1sivA:
18.4		 4q1yA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 4q1yA-1sivA:
18.4		 4q1yA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 10 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
 None
 0.55A 4q1yA-1sivA:
18.4		 4q1yA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 LEU A  24
GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  22
 None
 1.44A 4q1yA-1sivA:
18.4		 4q1yA-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.60A 4q1yB-1sivA:
18.5		 4q1yB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 4q1yB-1sivA:
18.5		 4q1yB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.80A 4q1yB-1sivA:
18.5		 4q1yB-1sivA:
51.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.45A 4q1yB-1sivA:
18.5		 4q1yB-1sivA:
51.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 GLY A  27
ASP A  29
ILE A  50
THR A  80
PRO A  81
 None
 0.37A 4q5mA-1sivA:
15.6		 4q5mA-1sivA:
28.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q5M_A_ROCA1101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 GLY A  27
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.60A 4q5mA-1sivA:
15.6		 4q5mA-1sivA:
28.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 None
 0.45A 4qgiA-1sivA:
18.1		 4qgiA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 11 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.81A 4qgiB-1sivA:
17.9		 4qgiB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.65A 4qgiB-1sivA:
17.9		 4qgiB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 4rvjA-1sivA:
18.5		 4rvjA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 1.05A 4rvjA-1sivA:
18.5		 4rvjA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.32A 4rvjA-1sivA:
18.5		 4rvjA-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 4rvjB-1sivA:
18.3		 4rvjB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.50A 4rvjB-1sivA:
18.3		 4rvjB-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 4rvjC-1sivA:
18.5		 4rvjC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 1.06A 4rvjC-1sivA:
18.5		 4rvjC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 11 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.33A 4rvjC-1sivA:
18.5		 4rvjC-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 4rvjD-1sivA:
18.3		 4rvjD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 9 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.50A 4rvjD-1sivA:
18.3		 4rvjD-1sivA:
48.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  48
ILE A  82
ILE A  84
 None
 0.70A 5e5jA-1sivA:
18.5		 5e5jA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.19A 5e5jA-1sivA:
18.5		 5e5jA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
ILE A  82
ILE A  84
 None
 0.51A 5e5jA-1sivA:
18.5		 5e5jA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  29
PRO A  81
ILE A  82
ILE A  84
 None
 1.35A 5e5jB-1sivA:
18.4		 5e5jB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.48A 5e5jB-1sivA:
18.4		 5e5jB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.82A 5e5jB-1sivA:
18.4		 5e5jB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
ILE A  84
 None
 1.16A 5e5kA-1sivA:
18.4		 5e5kA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.50A 5e5kA-1sivA:
18.4		 5e5kA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
 None
 0.90A 5e5kA-1sivA:
18.4		 5e5kA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		12 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ILE A  32
GLY A  49
ILE A  50
PRO A  81
ILE A  82
ILE A  84
 None
 0.43A 5e5kB-1sivA:
18.3		 5e5kB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ASP A  25
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  82
ILE A  84
 None
 0.75A 5e5kB-1sivA:
18.3		 5e5kB-1sivA:
53.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KMD_C_6UBC1304_1
(ION TRANSPORT
PROTEIN)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		4 / 5 ILE A  82
LEU A  89
GLY A  86
PHE A  85
 None
 0.96A 5kmdC-1sivA:
undetectable
5kmdD-1sivA:
undetectable		 5kmdC-1sivA:
15.09
5kmdD-1sivA:
15.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
ILE A  84
 None
 0.47A 5kqxA-1sivA:
18.3		 5kqxA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_1
(PROTEASE E35D-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 0.86A 5kqxA-1sivA:
18.3		 5kqxA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQX_A_ROCA101_2
(PROTEASE E35D-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.68A 5kqxB-1sivA:
18.2		 5kqxB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.30A 5kqyA-1sivA:
18.3		 5kqyA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_1
(PROTEASE E35D-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.36A 5kqyA-1sivA:
18.3		 5kqyA-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.45A 5kqyB-1sivA:
18.2		 5kqyB-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ALA A  28
ASP A  30
ILE A  50
PRO A  81
ILE A  84
 None
 0.70A 5kr0A-1sivA:
18.3		 5kr0A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.24A 5kr0A-1sivA:
18.3		 5kr0A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 LEU A  23
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
 0.54A 5kr0B-1sivA:
18.1		 5kr0B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ARG A   8
LEU A  23
ALA A  28
ASP A  30
GLY A  49
ILE A  50
 None
 0.96A 5kr1A-1sivA:
18.2		 5kr1A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_1
(PROTEASE PR5-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 10 ARG A   8
LEU A  23
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.69A 5kr1A-1sivA:
18.2		 5kr1A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_2
(PROTEASE PR5-DRV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.60A 5kr1B-1sivA:
18.0		 5kr1B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
 None
 0.41A 5kr2A-1sivA:
17.9		 5kr2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  49
THR A  80
PRO A  81
 None
 0.59A 5kr2A-1sivA:
17.9		 5kr2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.82A 5kr2A-1sivA:
17.9		 5kr2A-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 ARG A   8
LEU A  23
ASP A  30
PRO A  81
ILE A  84
 None
 1.04A 5kr2B-1sivA:
17.9		 5kr2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_2
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 11 LEU A  23
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.59A 5kr2B-1sivA:
17.9		 5kr2B-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 9 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
THR A  80
PRO A  81
 None
 0.71A 5kr2C-1sivA:
17.8		 5kr2C-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 9 ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
 None
 0.78A 5kr2C-1sivA:
17.8		 5kr2C-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 9 ARG A   8
LEU A  23
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.71A 5kr2D-1sivA:
18.4		 5kr2D-1sivA:
50.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.23A 5t2zA-1sivA:
18.9		 5t2zA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  84
 None
 0.49A 5t2zA-1sivA:
18.9		 5t2zA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.53A 5t2zA-1sivA:
18.9		 5t2zA-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 1.27A 5t2zB-1sivA:
18.8		 5t2zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.64A 5t2zB-1sivA:
18.8		 5t2zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
GLY A  48
ILE A  84
 None
 0.78A 5t2zB-1sivA:
18.8		 5t2zB-1sivA:
50.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ALA A  28
ASP A  29
ILE A  32
GLY A  48
ILE A  84
 None
 0.79A 5t8hA-1sivA:
18.3		 5t8hA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
GLY A  49
ILE A  50
ILE A  84
 None
 0.46A 5t8hA-1sivA:
18.3		 5t8hA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
GLY A  49
PRO A  81
ILE A  84
 None
 0.51A 5t8hA-1sivA:
18.3		 5t8hA-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  32
ILE A  50
PRO A  81
ILE A  84
 None
 0.58A 5t8hB-1sivA:
18.6		 5t8hB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		11 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
VAL A  47
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.42A 5t8hB-1sivA:
18.6		 5t8hB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_2
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ILE A  32
GLY A  48
PRO A  81
ILE A  84
 None
 0.95A 5t8hB-1sivA:
18.6		 5t8hB-1sivA:
53.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.20A 6dgxA-1sivA:
18.2		 6dgxA-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 LEU A  23
ASP A  25
ASP A  29
GLY A  49
ILE A  50
 None
 0.89A 6dgxA-1sivA:
18.2		 6dgxA-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.44A 6dgxA-1sivA:
18.2		 6dgxA-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.45A 6dgxA-1sivA:
18.2		 6dgxA-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.57A 6dgxA-1sivA:
18.2		 6dgxA-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.60A 6dgxB-1sivA:
18.5		 6dgxB-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.40A 6dgxB-1sivA:
18.5		 6dgxB-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.78A 6dgxB-1sivA:
18.5		 6dgxB-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 LEU A  23
ASP A  25
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.31A 6dgxB-1sivA:
18.5		 6dgxB-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.18A 6dh0A-1sivA:
18.2		 6dh0A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
 None
 0.54A 6dh0A-1sivA:
18.2		 6dh0A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
 None
 0.53A 6dh0B-1sivA:
18.6		 6dh0B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
 None
 0.38A 6dh0B-1sivA:
18.6		 6dh0B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
 None
 0.32A 6dh0B-1sivA:
18.6		 6dh0B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.20A 6dh3A-1sivA:
18.3		 6dh3A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 1.19A 6dh3A-1sivA:
18.3		 6dh3A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
ILE A  82
 None
 0.58A 6dh3A-1sivA:
18.3		 6dh3A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  82
ILE A  84
 None
 0.47A 6dh3A-1sivA:
18.3		 6dh3A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  82
ILE A  84
 None
 0.59A 6dh3A-1sivA:
18.3		 6dh3A-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.54A 6dh3B-1sivA:
18.6		 6dh3B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.39A 6dh3B-1sivA:
18.6		 6dh3B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.82A 6dh3B-1sivA:
18.6		 6dh3B-1sivA:
47.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.43A 6dh6A-1sivA:
18.3		 6dh6A-1sivA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.52A 6dh6B-1sivA:
18.5		 6dh6B-1sivA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.43A 6dh6B-1sivA:
18.5		 6dh6B-1sivA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 12 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.79A 6dh6B-1sivA:
18.5		 6dh6B-1sivA:
46.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.54A 6difA-1sivA:
18.4		 6difA-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.42A 6difA-1sivA:
18.4		 6difA-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.72A 6difB-1sivA:
18.4		 6difB-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
 0.47A 6difB-1sivA:
18.4		 6difB-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.58A 6dilA-1sivA:
18.3		 6dilA-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 12 ARG A   8
LEU A  23
ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
 None
 1.45A 6dilA-1sivA:
18.3		 6dilA-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.77A 6dilB-1sivA:
18.4		 6dilB-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		8 / 12 ARG A   8
LEU A  23
ASP A  25
GLY A  27
ALA A  28
GLY A  49
PRO A  81
ILE A  84
 None
 0.67A 6dilB-1sivA:
18.4		 6dilB-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  50
 None
 1.35A 6dj1A-1sivA:
18.5		 6dj1A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		10 / 12 ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.52A 6dj1A-1sivA:
18.5		 6dj1A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		6 / 12 ASP A  25
GLY A  27
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.74A 6dj1A-1sivA:
18.5		 6dj1A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.64A 6dj1B-1sivA:
18.7		 6dj1B-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		7 / 10 ASP A  25
ALA A  28
ASP A  29
GLY A  49
ILE A  50
PRO A  81
ILE A  84
 None
 0.40A 6dj2A-1sivA:
18.4		 6dj2A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		5 / 10 ASP A  25
ALA A  28
GLY A  48
PRO A  81
ILE A  84
 None
 0.72A 6dj2A-1sivA:
18.4		 6dj2A-1sivA:
49.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 1siv SIV PROTEASE
(Simian
immunodeficiency
virus) 		9 / 12 ARG A   8
ASP A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  50
PRO A  81
 None
 0.63A 6dj2B-1sivA:
18.8		 6dj2B-1sivA:
49.40